Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease

British Journal of Surgery

Volumn 97, Issue 9, 2010, Pages 1340-1347

  Maeda, Y ^a,f   Ng, S C ^a   Durdey, P ^b   Burt, C ^b   Torkington, J ^c   Rao, P Kumar Dhruva ^c   Mayberry, J ^e   Moshkovska, T ^e   Stone, C D ^g   Carapeti, E ^d   Vaizey, C J ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c LLANDOUGH HOSPITAL   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e LEICESTER GENERAL HOSPITAL   (United Kingdom)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; METRONIDAZOLE;

ADULT; ANUS DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; OINTMENT; PAIN; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; ANTI-BACTERIAL AGENTS; ANUS DISEASES; CROHN DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METRONIDAZOLE; OINTMENTS; PAIN; PATIENT SATISFACTION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 77956410790     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7121     Document Type: Conference Paper

References (19)

1. Keighley MR, Allan RN. Current status and influence of operation on perianal Crohn's disease. Int J Colorectal Dis 1986; 1: 104-107.
2. Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. AmJ Gastroenterol 2006; 101: 1012-1023.
3. Schwartz DA, Loftus EVJr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875-880.
4. Kamm. MA, Ng SC. Perianal fistulizing Crohn's disease: a call to action. Clin. Gastroenterol Hepatol 2008; 6: 7-10.
5. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350: 876-885.
6. Bernstein LH, Frank MS, Brandt LJ, Boley SJ. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980; 79: 599.
7. Jakobovits J, Schuster MM. Metronidazole therapy for Crohn's disease and associated fistulae. Am J Gastroenterol 1984; 79: 533-540.
8. Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1982; 83: 383-387.
9. Stringer EE, Nicholson TJ, Armstrong D. Efficacy of topical metronidazole (10 percent) in the treatment of anorectal Crohn's disease. Dis Colon Rectum 2005; 48: 970-974.
10. Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 1995; 20: 27-32.
11. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233.
12. Bressler B, Sands BE. Review article: Medical therapy for fistulizing Crohn's disease. Aliment Pharmacol Ther 2006; 24: 1283-1293.
13. Maeda. Y, Ng SC, Durdey P, Burt C, Torkington J, Dhurava-Rao P et al. Metronidazole 10 per cent ointment improves symptoms in perianal Crohn's disease with low systemic exposure. Gut 2009; 58(Suppl 1): A14.
14. Jeshion WC, Larsen KL, Jawad AF, Piccoli DA, Verma R, Mailer ES et al. Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children. J Clin Gastroenterol 2000; 30: 294-298.
15. Arndt H, Palitzsch KD, Grisham MB, Granger DN. Metronidazole inhibits leukocyte-endothelial cell adhesion in rat mesenteric venules. Gastroenterology 1994; 106: 1271.-1276.
16. Leite AZ, Sipahi AM, Damião AO, Coelho AM, Garcez AT, Machado MC et ai. Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism. Gut 2001; 48: 163-167.
17. Nishimuta K, Ito Y. Effects of metronidazole and tinidazole ointments on models for inflammatory dermatitis in mice. Arch Dermatol Res 2003; 294: 544-551.
18. Schwartz DA, Wiersema MJ, Dudiak KM, Fletcher JG, Clain JE, Tremaine WJ et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 2001; 121: 1064-1072.
19. Ng SC, Plamondon S, Gupta A, Burling D, Swatton A, Vaizey CJ et al. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas. AmJ Gastroenterol 2009; 104: 2973-2986.